Chimeric G proteins made by replacing the COOH-terminal heptapeptide of G␣q with the COOH-terminal heptapeptide of G␣s or G␣i were used to assess the relative coupling of ␤3-adrenergic receptor (␤3-AR) splice variants (␤3A and ␤3B) to G␣s and G␣i. The G␣q/s and G␣q/i chimeras transformed the response to receptor activation from regulation of adenylyl cyclase to mobilization of intracellular calcium (Ca 2ϩ i). Complementary high-throughput and single-cell approaches were used to evaluate agonist-induced coupling of the receptor to the G protein chimeras. In cells stably transformed with rat ␤3-AR, transfected with the G protein chimeras, and evaluated using a scanning fluorometer, ␤3-AR-induced coupling to G␣q/s produced a rapid eightfold increase in Ca 2ϩ i followed by a slow decay to levels 25% above baseline. G␣q/i also linked rat ␤3-AR to mobilization of Ca 2ϩ i in a similar time-and agonist-dependent manner, but the net 2.5-fold increase in Ca 2ϩ i was only 30% of the response obtained with G␣q/s. Activation of the rat ␤3-AR also increased GTP binding to endogenous G␣i threefold in membranes from CHO cells stably transformed with the receptor. A complementary single-cell imaging approach was used to assess the relative coupling of mouse ␤3A-and ␤3B-AR to G␣i under conditions established to produce equivalent agonist-dependent coupling of the receptor splice variants to G ␣q/s and to increases in intracellular cAMP through endogenous G ␣s. The ␤ 3A-and ␤3B-AR coupled equivalently to G␣q/i, but the temporal patterns of Ca 2ϩ i mobilization indicated that coupling was significantly less efficient than coupling to G ␣q/s. Collectively, these findings indicate less efficient but equivalent coupling of ␤ 3A-and ␤ 3B-AR to G␣i vs. G␣s and suggest that differential expression of the splice variants would not produce local differences in signaling networks linked to ␤ 3-AR activation.
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Laboratories of 1 Complementary high-throughput and single-cell approaches were used to evaluate agonist-induced coupling of the receptor to the G protein chimeras. In cells stably transformed with rat ␤3-AR, transfected with the G protein chimeras, and evaluated using a scanning fluorometer, ␤3-AR-induced coupling to G␣q/s produced a rapid eightfold increase in Ca 2ϩ i followed by a slow decay to levels 25% above baseline. G␣q/i also linked rat ␤3-AR to mobilization of Ca 2ϩ i in a similar time-and agonist-dependent manner, but the net 2.5-fold increase in Ca 2ϩ i was only 30% of the response obtained with G␣q/s. Activation of the rat ␤3-AR also increased GTP binding to endogenous G␣i threefold in membranes from CHO cells stably transformed with the receptor. A complementary single-cell imaging approach was used to assess the relative coupling of mouse ␤3A-and ␤3B-AR to G␣i under conditions established to produce equivalent agonist-dependent coupling of the receptor splice variants to G ␣q/s and to increases in intracellular cAMP through endogenous G ␣s. The ␤ 3A-and ␤3B-AR coupled equivalently to G␣q/i, but the temporal patterns of Ca 2ϩ i mobilization indicated that coupling was significantly less efficient than coupling to G ␣q/s. Collectively, these findings indicate less efficient but equivalent coupling of ␤ 3A-and ␤ 3B-AR to G␣i vs. G␣s and suggest that differential expression of the splice variants would not produce local differences in signaling networks linked to ␤ 3-AR activation.
␤-adrenergic receptor; G proteins; cyclic adenosine monophosphate; signaling plasticity ␤-ADRENERGIC RECEPTORS (␤-AR) belong to the superfamily of 7-transmembrane-domain G protein-coupled receptors that increase intracellular cAMP by coupling to and activating G ␣ s, but ␤ 3 -ARs are distinct from classical ␤ 1 -and ␤ 2 -AR in many ways. Pharmacological studies demonstrate that ␤ 3 -ARs are either poorly antagonized by (e.g., propranolol) or partially activated by (e.g., CGP 12177A, pindolol) conventional nonselective and ␤ 1 /␤ 2 -AR antagonists (26) . Another important difference is that ␤ 1 /␤ 2 -ARs are subject to desensitization, which occurs by phosphorylation of serines and threonines in the intracellular COOH-terminal tail by G protein receptor kinase (GRK) and phosphorylation of the third intracellular loop by PKA (2, 29) . However, the ␤ 3 -AR has fewer serine and threonine residues in the COOH-terminal tail and lacks the consensus PKA target sequence in the third intracellular loop (12) . PKA-dependent phosphorylation of this region in ␤ 1 /␤ 2 -ARs reduces their affinity for G ␣ s and increases their affinity for G ␣ i, resulting in the "switch" that is observed following chronic agonist stimulation of ␤ 1 /␤ 2 -ARs (10). These structural differences limit posttranslational regulation of the ␤ 3 -AR and make it less sensitive to agonist-induced desensitization (30) .
Unlike the ␤ 1 /␤ 2 -ARs, the ␤ 3 -AR contains introns (21) . Alternative splicing generates two splice variants of the mouse ␤ 3 -AR (␤ 3A -AR and ␤ 3B -AR) that differ in their COOHterminal tails (13) . Interestingly, the ␤ 3B -AR has two additional serine residues in its COOH-terminal tail. A recent study reported that mutating these residues to alanine had no effect on receptor binding to the antagonist 125 I-cyanopindolol (ICYP) but completely blocked agonist-dependent increases in cAMP (39) . Although it is unclear whether the receptor is regulated by phosphorylation of these serines (Ser 388 and Ser 389 ), these and previous findings (23) indicate that the COOH termini of ␤ 3 -ARs are important for functional coupling to G proteins. The two ␤ 3 -AR splice variants share a common pharmacology but differ in their tissue distribution. The ␤ 3A -AR is the predominant isoform among tissues studied to date (13) . Highest levels of the less common ␤ 3B -AR are found in hypothalamus, cortex, and white adipose tissue (WAT), whereas the lowest levels are found in the ileum and brown adipose tissue (BAT) (13) . The ␤ 3B -AR makes up ϳ21% of total ␤ 3 -AR mRNA in WAT, whereas the ␤ 3B -AR comprises only 7% of total ␤ 3 -AR mRNA in BAT (13) .
The significance of differential expression of the ␤-AR splice variants is inferred from previous studies showing that the ␤ 3 -AR is capable of coupling to and activating G ␣ i (4, 40) , and recent work from Hutchinson et al. (23) reporting that the ␤ 3B -AR, but not the ␤ 3A -AR, can activate G ␣ i. Thus differences in expression of ␤ 3B -AR splice variants between BAT and WAT could lead to activation of dual signals in WAT (G ␣ s and G ␣ i), whereas in BAT, signaling would occur primarily through G ␣ s. If correct, this could produce tissue-specific differences in translation of sympathetic input. However, the findings of differential coupling of ␤ 3 -AR splice variants to G ␣ i were based on experiments using pertussis toxin (PTX) to inactivate receptor coupling to G ␣ i (23) . PTX pretreatment increased the maximal cAMP response to CL-316243 in cells transfected with the ␤ 3B -AR, but not in cells transfected with the ␤ 3A -AR, leading the authors to conclude differential coupling of the receptor splice variants to G ␣ i. PTX has been shown to have a number of signaling effects that are independent of ADP ribosylation of G ␣ i, such as activation of ERK1/2 (15), tyrosine kinases (28), Toll-like receptor 4 (25) , and NF-B (24) . These and other G ␣ i-independent effects of PTX affect signaling crosstalk, cell morphology, and cell function and have the potential to confound interpretation of receptor-G protein interactions based on downstream readouts. To assess relative coupling of ␤ 3 -AR splice variants to G ␣ s and G ␣ i in the absence of PTX, two experimental approaches were used. The first approach used a cross-linkable analog of GTP to measure receptor-dependent binding of GTP by G ␣ i (16) , and the second approach used chimeric G proteins developed by Conklin and colleagues (7, 8) and Coward et al. (9) . The G protein chimeras, prepared by replacing the COOH-terminal heptapeptide of G q ␣ with the COOH terminus of G ␣ s or G ␣ i, transform the response to receptor-dependent G protein activation from regulation of adenylyl cyclase to mobilization of intracellular calcium (Ca 2ϩ i ). Using Chinese hamster ovary (CHO) cells transfected with ␤ 3 -AR splice variants and the respective approaches, we find that ␤ 3A -AR and ␤ 3B -AR couple equivalently to G ␣ i but ϳ70% less effectively than they couple to G ␣ s.
MATERIALS AND METHODS

Materials.
All tissue culture reagents other than fetal bovine serum (Hyclone, Logan, UT) were from Invitrogen (Carlsbad, CA). Fugene 6 was purchased from Roche (Indianapolis, IN). Fluo 3-AM was from Molecular Probes (Carlsbad, CA), and the FLIPR calcium assay kit was from Molecular Devices (Sunnyvale, CA). All other reagents were from Sigma-Aldrich (St. Louis, MO). The ␤ 3-AR agonist CL-316243 was a gift from Dr. Kurt Steiner at Wyeth Ayerst (Monmouth Junction, NJ). The GTP photoaffinity probe, 4-azidoanilido-[␣- 32 P]GTP (AA-GTP), was obtained from ALT (Lexington, KY). The mouse monoclonal HA antibody (clone 12CA5) was obtained from Roche (San Diego, CA). The 125 I-labeled cAMP-tyrosyl methylester (TME) was prepared by iodination of cAMP-TME and purification of labeled from unlabeled ligand by C 18 reverse-phase HPLC as previously described (17) .
Cell culture. CHO-K1 cells were obtained from American Type Culture Collection (Manassas, VA) and maintained in F-12 K medium supplemented with 10% (vol/vol) FBS, 1% penicillin (100 U/ml), and streptomycin (100 mg/ml) at 37°C in a humidified 5% CO 2 atmosphere. The CHO cells used for study never exceeded passage 20. CHO cells stably transformed with the M1 muscarinic receptor (M1-CHO) were cultured in Ham's F-12 medium supplemented with 10% FBS, glutamine, penicillin, and streptomycin and 50 g/ml G418 at 37°C in a humidified 5% CO 2 atmosphere.
Plasmids. The expression construct for the rat ␤ 3-AR was provided by Dr. James Granneman (Wayne State University, Detroit, MI). The expression constructs for the mouse ␤ 3A-AR and ␤3B-AR were provided by Dr. Roger Summers (Monash University, Victoria, Australia), and the expression constructs for HA-tagged G ␣q/s and G␣q/i chimeras were provided by Dr. Bruce Conklin (Gladstone Institute, University of California, San Francisco, CA). CHO cells stably transformed with the serotonin (5-HT 1A) receptor were provided by Dr. John Raymond (Medical University of South Carolina, Charleston, SC). The inserts for the rat ␤ 3-AR, mouse ␤3A-and ␤3B-AR were subcloned into the pcDNA 3. i through activation of phospholipase C. CHO cells stably transformed with the rat ␤ 3-AR were prepared by transfecting the ␤ 3-AR into CHO cells with Lipofectamine (Invitrogen) according to the manufacturer's instructions. G-418 was used as the selection agent (500 g/ml) for 3 wk, and selected clones were screened and selected on the basis of ␤ 3-AR agonist-dependent increases of intracellular cAMP. Selected clones were maintained in G-418 (50 g/ml).
Agonist-dependent coupling of rat ␤3-AR to endogenous G␣i. To measure directly whether the rat ␤ 3-AR could activate endogenous G ␣i in our cell line, CHO cell plasma membranes from cells stably expressing the rat ␤ 3-AR or human 5-HT1A receptor were prepared by differential centrifugation and incubated with 0.5 Ci of 4-azidoanilido-[␣-
32 P]GTP (AA-GTP) and 3 M GDP in the presence or absence of 1 M CL-316243 (rat ␤3-AR) or 1 M serotonin (human 5-HT1A receptor) for 3 min as previously described (16, 37) . Thereafter, the membranes were collected, and bound AA-GTP was crosslinked to G␣i proteins under UV light (254 nm) for 3 min at 4°C. Proteins were resolved by SDS-PAGE, visualized on film, and quantitated by scanning densitometry to assess receptor-dependent G␣i activation (16) .
Measurement of rat ␤3-AR coupling to G protein chimeras with FLEX Station. For automated calcium measurements using the FLEX Station, initial studies were conducted with CHO cells stably transformed with M1 muscarinic receptor, which couples to endogenous Gq␣ and mobilizes Ca 2ϩ i through activation of phospholipase C. The M1 cell line served as a positive control to establish assay conditions and validate the method. Thereafter, CHO cells stably transformed with M1 receptor or the rat ␤3-AR were plated overnight at a seeding density of 2.2 ϫ 10 6 /100-mm dish. The following day, CHO cells from the ␤3-AR line were transiently transfected with the G␣q/s or G␣q/i chimeras, or vector alone using Fugene 6 (3 g cDNA/100-mm dish). In initial experiments, CHO cells expressing the ␤3-AR were also cotransfected with an expression construct for the red fluorescent protein DsRed and evaluated by fluorescence microscopy at 600 nm to evaluate transfection efficiency (ϳ45%) and confirm equal efficiency between cells transfected with each G protein chimera. After 24 h, cells were detached and split using trypsin-EDTA (0.5 mM) and seeded on polylysine-coated 96-well black-walled plates at a density of 80,000 cells/well. Plated cells were loaded with Molecular Device's FLIPR calcium assay kit for 90 min at 37°C according to the manufacturer's instructions. Without being washed, the plates were placed in the FLEX Station, and its integrated fluidics were used to add buffer to lift loose cells first, establish a stable baseline recording, and then add the desired concentration of the respective agonist for each cell type. Carbachol was used for the M1-CHO line, and CL-316243 was used for the ␤3-AR line. The excitation fluorescence was 485 nm, and the emission fluorescence was 520 nm using a 515-nm emission cutoff filter. Seven individual fields on the bottom of each well were set for the fluorescence path measurement. Agonistdependent changes in fluorescence were recorded and exported to GraphPad Prism (San Diego, CA) for analysis of kinetic parameters.
Transient transfection of ␤3A-and ␤3B-AR and G protein chimeras for single-cell fluorescense microscopy. CHO cells were seeded at a density of 20,000 cells/6-well plate in F-12 K medium described above and incubated overnight at 37°C in a humidified 5% CO2 atmosphere. The following day, cells were cotransfected with the indicated combination of expression constructs (2.4 g of total cDNA) and Fugene 6 in a 1:3 ratio according to manufacturer's instructions for 24 h. To positively identify transfected cells for study, the expression construct for red fluorescent protein DsRed was included during cotransfection with the receptor and G protein constructs. The cells that were positive for DsRed were identified and analyzed by fluorescence microscopy. The DsRed was chosen because it has an excitation/emission spectrum distinct from the probe (Fluo 3) used for measurement of changes in intracellular calcium.
The cells were evaluated 16 h after transfection by placing them in 1 ml of the F-12 K medium without serum but containing 10 mM HEPES, pH 7.4, 1 mM probenecid, and 10 M Fluo 3-AM for 30 -45 min at room temperature in the dark. The cells were washed three times with Hanks' buffered salt solution supplemented with 10 mM HEPES, pH 7.4 (HHBSS), and placed in 1.9 ml of HHBSS. Culture dishes were then mounted onto the microscope stage (Nikon), and DsRed-expressing cells were identified for analysis. Fluo 3 fluorescence was measured in these cells by use of an excitation filter of 495 nm on the selection illuminator (Illuminator D6), an emitter of 520 nm, and a low light camera (Photometrics) interfaced with the microscope and controlled by Metamorph software. For time lapse fluorescence measurements, cells chosen for further analysis were well distanced from one another and uniformly loaded with Fluo 3. The stability of the fluorescence background was checked with the addition of 50 l of HHBSS buffer. Evaluation of receptor coupling to mobilization of Ca 2ϩ i through the G protein chimeras was initiated by addition of agonists (50 l) and monitored through time using Metamorph software. The relative changes in [Ca 2ϩ ]i were measured as changes in fluorescence (F), where F is the fluorescence intensity of an area of interest (i.e., within DsRed-expressing cells) before stimulation (denoted as 100%), and ⌬F is the change from this value during the time course of stimulation. Background fluorescence (from a designated area without Fluo 3-loaded cells) was subtracted from the fluorescence of the Fluo 3-loaded cells before calculations were performed. Numerical fluorescence data were exported to Graphpad Prism for calculation of the following kinetic parameters: maximum fluorescence, duration of peaks, and frequency of peaks per 5 min of measurements. These variables were analyzed to compare relative coupling of ␤3A-AR and ␤3B-AR to the G␣q/s and G␣q/i chimeras.
Measurement of intracellular cAMP. Cells from selected experiments were preincubated for 5 min with 100 M IBMX and stimulated for 10 min with 10 M CL-316243. The reaction was stopped with ice-cold TCA (2.5% final concentration). The supernatants were transferred into Eppendorf tubes and centrifuged, and cAMP was measured in the clear supernatants by radioimmunoassay as described previously (17) .
Measurement of adenylyl cyclase activity. Crude membranes were prepared from CHO cells transfected for 48 h with either the ␤3A-AR or ␤3B-AR as previously described (16, 38) . The membranes were resuspended at 1 mg/ml in 25 mM HEPES (pH 7.4) containing 140 mM NaCl, 40 M leupeptin, 1 g/ml soybean trypsin inhibitor, and 1 mM EDTA and snap-frozen with liquid nitrogen in 100-g aliquots for subsequent measurement of adenylyl cyclase and receptor binding to 125 I-cyanopindolol (ICYP). Adenylyl cyclase activity was measured by incubating 10-g aliquots of membranes from each receptor preparation for 10 min at 30°C in a buffer containing 50 mM TES (pH 7.4), 4 mM MgCl2, 2 mM creatine phosphate, 25 U/ml creatine phosphokinase, 100 M ATP, 10 M GTP, and incremental concentrations of CL-316243 as previously described (17) . The reaction was stopped with ice-cold TCA, and cAMP formed in the reaction was measured as before (17) . Dose response curves were characterized using the four-paramater logistic ogive in relation to log dose as described previously (19) .
Measurement of ICYP binding. Radioligand binding assays were conducted with membranes from CHO cells transfected with ␤3A-AR or ␤3B-AR by incubating membranes from each source (10 -15 g) with 40 pM ICYP in 25 mM HEPES (pH 7.4) containing 12.5 mM MgCl2 for 1 h at 37°C, as described previously (5). Bound ICYP was collected on filters in a Skatron cell harvester (Molecular Devices), and counts per minute of bound ICYP were converted to femtomoles of ICYP bound based on the specific activity of the ICYP used (2, 200 Ci/mmol).
Measurement of G ␣q/s and G␣q/i expression. Whole cell extracts were prepared from CHO cells cotransfected with G␣q/s or G␣q/i, and the ␤3-AR expression vector and G␣q/s and G␣q/i expression were measured in 200-g aliquots from each chimera. Identical whole cell extracts from cells cotransfected with empty vector and ␤3-AR expression vector were used as a negative control. The blots were probed with 12CA5 monoclonal HA antibody and visualized by standard ECL procedure. Band intensity was quantitated by densitometry using the Versadoc system (Bio-Rad).
Methods of analysis. The agonist-dependent increases in cAMP for each receptor/G protein chimera combination were compared using a two-way analysis of variance, with post hoc testing of group means using the Bonferroni correction. Specific binding of ICYP in membranes from CHO cells transfected with empty vector or ␤ 3A-AR or ␤ 3B-AR expression constructs was compared by one-way analysis of variance. To compare the ability of the rat ␤ 3-AR to couple to G␣q/s vs. G ␣q/i, maximal agonist-dependent increases in [Ca 2ϩ ]i measured with the FLEX Station were compared using a one-tailed t-test (␣ ϭ 0.05). The relative coupling of mouse ␤ 3A-AR and ␤3B-AR to G␣q/s vs. G ␣q/i was measured using fluorescence microscopy and evaluated by comparing the patterns of agonist-induced Ca i oscillations produced by agonist were calculated from each recording and compared using two-way analysis of variance. A one-way analysis of variance was used to compare receptor-dependent binding of AA-GTP to endogenous G ␣i and to compare ICYP binding in membranes from cells transfected with the ␤ 3A-AR or ␤3B-AR. Post hoc testing of group means was made using the pooled error term to calculate standard errors. Protection against type I errors was set at 5% (␣ ϭ 0.05).
RESULTS
Sequence differences between rat and mouse ␤ 3 -AR. Amino acid sequences of the rat ␤ 3 -AR (20) and mouse ␤ 3A -AR and ␤ 3B -AR (13) splice variants used herein are presented in Fig. 1 . The first 387 amino acids of the mouse ␤ 3A -and ␤ 3B -AR are identical, but the ␤ 3B -AR has a unique COOH terminus (SS-LLREPRHLYTCLGYP) that is four residues longer and completely distinct from the COOH terminus of the mouse ␤ 3A -AR (RFDGYEGARPFPT). Compared with the mouse ␤ 3 -AR, the first 387 residues of the rat ␤ 3 -AR contain 21 amino acid substitutions, and, as shown in Fig. 1 , the majority are conservative changes. This translates into 95.4% homology between the rat ␤ 3 -AR and the mouse ␤ 3 -AR splice variants in this region of the protein. Interestingly, the COOH terminus of the rat ␤ 3 -AR is identical to that of the mouse ␤ 3A -AR except for a nonconservative substitution of glutamic acid for alanine at position 395 (Fig. 1) . Thus the similarities and differences among the three receptors provide an initial basis for evaluating the role of specific sequences in differential coupling of the ␤ 3 -AR to G protein subtypes.
Coupling of transfected rat and mouse ␤ 3 -ARs to endogenous G ␣ s and G ␣ i. To confirm that transfected ␤ 3 -AR receptors were biologically active and to establish conditions of equivalent functional expression for the various studies, initial experiments were conducted with stably transformed CHO cells expressing the rat ␤ 3 -AR and CHO cells transiently transfected with mouse ␤ 3 -AR splice variants and G protein chimeras. In the first of two sets of experiments conducted with the stably E706 ␤3A-AND ␤3B-ADRENERGIC RECEPTOR COUPLING TO G PROTEINS transformed rat ␤ 3 -AR line, the cells were transiently transfected with empty vector or vectors for G ␣ q/s or G ␣ q/i, followed by measurement of agonist-dependent increases in intracellular cAMP. Basal cAMP concentration was similar in each line (empty vector 1.85 Ϯ 0.15, G ␣ q/s 1.04 Ϯ 0.13, G ␣ q/i 2.14 Ϯ 0.14 pmol/well), and a 10-min incubation with the ␤ 3 -AR agonist CL-316243 (10 M) produced similar increases in intracellular cAMP in each group (empty vector 6.51 Ϯ 1.08, G ␣ q/s 5.69 Ϯ 0.86, G ␣ q/i 6.47 Ϯ 0.73 pmol/well). These results provide no evidence that transient transfection of G protein chimeras affects functional coupling of the rat ␤ 3 -AR to endogenous G ␣ s. They also provide a common basis for comparing the relative coupling of the rat ␤ 3 -AR to the G ␣ q/s and G ␣ q/i chimeras. In the second set of experiments, incubation of plasma membranes from this cell line with the photocross-linkable GTP analog AA-GTP and receptor agonist (1 M CL-316243) produced a threefold increase in binding of AA-GTP to proteins migrating at 40 -41 kDa (Fig. 2) . AA-GTP binding was not increased by CL-316243 in plasma membranes from cells transformed with empty vector, but in membranes from cells expressing the canonical G ␣ i-coupled receptor 5-HT 1A , the receptor agonist (serotonin) produced a five-to sixfold increase in AA-GTP binding to a 41-kDa band (Fig. 2) that we previously showed (16) by immunoprecipitation to contain both G ␣ i-2 and G ␣ i-3. Collectively, these findings indicate that the rat ␤ 3 -AR couples to endogenous G ␣ i in an agonist-dependent manner and that transient transfection of G protein chimeras does not affect receptor coupling to endogenous G ␣ s.
Similar control experiments were run with CHO cells transiently transfected with the mouse ␤ 3 -AR splice variants and G protein chimeras. In this case, it was essential to obtain equivalent functional receptor expression between CHO cells transfected with ␤ 3A -AR vs. ␤ 3B -AR so that differences in G protein coupling could be properly attributed to differences in receptor sequence rather than expression. And as addressed above, it was also important to establish that cotransfection with the G protein chimeras did not selectively alter receptor function. By use of basal and agonist-induced increases in cAMP as end points, two-way analysis of variance provided no evidence of an interaction between receptor splice variant and G protein chimera with either response variable (Fig. 3, A and B) . Post hoc testing of group means confirmed that cotransfection of G ␣ q/s or G ␣ q/i had no effect on basal or agonist-induced cAMP with either receptor splice variant (Fig. 3, A and B) . In addition, the CL-316243-induced increases in intracellular cAMP did not differ between CHO cells transfected with ␤ 3A -AR vs. ␤ 3B -AR, regardless of G protein chimera (Fig. 3, A  and B) . Collectively, these findings support the conclusion that transient transfection of the receptor splice variants using our protocol produced equivalent functionality with respect to agonist-dependent increases in cellular cAMP. Fig. 1 . Amino acid sequence alignment of rat ␤3-AR (adrenergic receptor), mouse ␤3A-AR, and ␤3B-ARs. The first 387 amino acids of the mouse ␤3-AR isoforms are identical. The 21 amino acid substitutions in the rat ␤3-AR sequence are identified, which translates to 95.4% homology between rat and mouse ␤3-ARs in this region. Mouse ␤3B-AR has a unique COOH terminus with 17 amino acids (SSLLREPRHLYTCLGYP), which is distinct from the COOH-terminal 13-amino acid sequence (RFDGYEGARPFPT) of the mouse ␤3A-AR. Rat ␤3-AR and mouse ␤3A-AR COOH-terminal sequences are identical, except for a glutamic acid-foralanine substitution at position 395. (Fig. 3C) . Estimates of potency (␤ 3A -AR 85.0 Ϯ 9.1 and ␤ 3B -AR 43.2 Ϯ 8.9 nM) and efficacy (␤ 3A -AR 1.44 Ϯ 0.19 and ␤ 3B -AR 1.33 Ϯ 0.14 pmol⅐min Ϫ1 ⅐mg Ϫ1 ) from the fitted curves did not differ between receptor isoforms (Fig. 3C) . These findings complement our findings in intact cells (Fig. 3, A and B) and further support the conclusion of equivalent functionality of the transfected receptor isoforms.
Comparison of ␤ 3A -AR or ␤ 3B -AR binding to ICYP. The membranes used to measure adenylyl cyclase activation were also used to assess the respective binding of the receptor isoforms to ICYP. Binding of ICYP was compared at 40 pM ICYP, which is ϳ20-fold lower than the estimated dissociation constant (880 Ϯ 90 pM) of ICYP for the mouse ␤ 3 -AR (35) . This concentration provides a sensitive test for differences in receptor density between preparations. As expected, specific ICYP binding was not detected in membranes from cells transfected with empty vector (Fig. 3D) . Figure 3D also suggests slightly higher ICYP binding in the ␤ 3A -AR vs. ␤ 3B -AR membrane preparations, but analysis of variance provided no evidence that the means were different (P Ͼ 0.05). Collectively, the results presented in Fig. 3 , A-D, show comparable expression of the ␤ 3 -AR isoforms, using our transfection protocol, and establish a common basis for comparing their coupling to G protein chimeras in subsequent experiments.
Comparison of G protein chimera expression. Finally, whole cell extracts from CHO cells transiently transfected with the ␤ 3 -AR expression vector and the G ␣ q/s or G ␣ q/i expression constructs were used to examine the relative expression of the G protein chimeras by Western blotting. The G protein chimeras were detected via an internal HA epitope tag, and Fig. 3E shows that expression of the G protein chimeras was not detected in cells transfected with empty vector and that the respective G protein chimeras were expressed at similar levels in CHO cells transfected with each chimera. Endogenous G ␣ q, G ␣ s, and G ␣ i expressions were also compared between the CHO cells transfected with each chimera and the CHO cells transfected with empty vector. We found no evidence that endogenous G protein expression was altered by the G protein chimeras (data not shown). Considered together, these findings establish that comparisons of receptor-G protein coupling are based on comparable expression of the ␤ 3 -AR isoforms and the G protein chimeras, providing a common basis for comparing coupling efficiency of the ␤ 3 -AR isoforms to the respective G protein chimeras.
Comparison of rat ␤ 3 -AR coupling to G ␣ s vs. G ␣ i. Initial control experiments were conducted with CHO cells stably expressing the M1-CHO or the rat ␤ 3 -AR. The M1-CHO couples to endogenous G ␣ q and was used as a positive control to optimize Ca 2ϩ -sensitive probe loading and receptor-dependent mobilization of Ca 2ϩ i . Initial experiments showed that baseline fluorescence was stable and not affected by addition of buffer to either M1-CHO or rat ␤ 3 -AR CHO. However, addition of 1 M carbachol produced a rapid increase of ϳ15,000 relative fluorescence units above baseline in M1-CHO cells (Fig. 4) . In contrast, addition of CL-316243 to ␤ 3 -AR-expressing CHO cells had no effect on Ca 2ϩ i (Fig. 4) , indicating that the ␤ 3 -AR does not couple to endogenous G q ␣. This control experiment also established that the ␤ 3 -AR does not alter Ca 2ϩ i through its coupling to G ␣ s or G ␣ i. Carbachol had no effect on Ca 2ϩ i in ␤ 3 -AR CHO or untransfected CHO cells (not shown). To test whether the rat ␤ 3 -AR can couple to G ␣ i and determine its relative coupling efficiency to G ␣ s and G ␣ i, CHO cells stably expressing the rat ␤ 3 -AR and transiently transfected with empty vector, G ␣ q/s, or G ␣ q/i were monitored after addition of 10 M CL-316243 to the respective cells. In G ␣ q/s-transfected cells, the agonist produced a rapid mobilization of Ca 2ϩ i (Fig. 5) , which decayed progressively to 4,000-to 5,000-fold fluorescence units over basal in the 2 min following agonist addition. The rat ␤ 3 -AR also coupled to G ␣ q/i and mobilized Ca 2ϩ i in similar rapid fashion after addition of agonist, but in this case the increase averaged 3,000 relative fluorescence units over basal in replicate experiments (Fig. 5) . A time-dependent decay from peak Ca 2ϩ i was observed in these cells to ϳ2,000 units over basal. Addition of CL-316243 had no effect on mobilization of Ca 2ϩ i in ␤ 3 -AR-expressing CHO cells transfected with empty vector (not shown). In separate control experiments, recordings from CHO cells transfected with the G protein chimeras alone showed stable baselines and no response to addition of the ␤ 3 -AR agonist (not shown). Collectively, these experiments establish that the rat ␤ 3 -AR functionally couples to the G ␣ q/s chimera in an agonistdependent manner and produces a robust mobilization of Ca 2ϩ i . The results show that the G ␣ q/i chimera can also couple the rat ␤ 3 -AR to mobilization of Ca 2ϩ i , although the efficiency of the coupling is only 30% of the response with G ␣ q/s (Fig. 5) .
Comparison of mouse ␤ 3A -AR and ␤ 3B -AR coupling to G ␣ s vs. G ␣ i using digital video microscopy. Measurement of agonist-induced Ca 2ϩ i mobilization with the FLEX Station pro- mobilization (e.g., oscillations vs. monotonic) are agonist concentration dependent (1, 22, 41) , initial studies were conducted with CHO cells stably transformed with the M1-CHO to establish how incremental receptor activation is translated with our detection system in this cell type. A saturating concentration of carbachol (10 M) evoked a large, fourfold increase in Ca 2ϩ i followed by a fast and then slow decline of Ca 2ϩ i over the following 4 min (Fig. 6A ). All cells in the viewing field responded simultaneously, so it was necessary to plate cells at low density to resolve and record from individual cells. This dose of carbachol produced a mean maximal increase in relative fluorescence over basal fluorescence of 382.2 Ϯ 35.5% (Fig. 6A) . A similar pattern of Ca 2ϩ i mobilization was also produced with 1 M and 100 nM carbachol (not shown), but at 10 nM the initial maximal increase in Ca 2ϩ i was about twofold lower than the response with 10 M carbachol (Fig. 6, A and  B) . The response to 10 nM carbachol also differed in that after the initial peak Ca 2ϩ i decreased and increased in an oscillatory manner. On the basis of our recent work, we attribute this oscillatory pattern to an interplay between calcium releasereuptake mechanisms (22) . Treatment of cells with a threshold dose of 1 nM carbachol produced a rapid mobilization of Ca 2ϩ i
followed by an oscillatory pattern of change in Ca 2ϩ i (Fig. 6C ).
This concentration of carbachol produced a maximal increase in Ca 2ϩ i of 168 Ϯ 12% with a peak duration of 30 Ϯ 4 s, but after each peak Ca 2ϩ i returned to the baseline observed prior to initial agonist treatment (Fig. 6C) . The oscillatory rise and fall in Ca 2ϩ i had intervals between the peaks of ϳ2 min, and the peaks showed a gradual decline in magnitude of the peak signal (Fig. 6C) . The results indicate that progressive, agonist-dependent increases in M1-CHO/G ␣ q coupling transform the temporal pattern of Ca 2ϩ i mobilization from a purely oscillatory pattern to a monotonic, biphasic decay pattern with full coupling. Although intermediate levels of agonist produced an intermediate pattern containing elements of both response types (Fig. 6B) , and although a comprehensive dose-response series was not conducted, the results argue that the progression of response patterns is a reflection of incremental recruitment of G ␣ q to liganded receptor.
The present evaluation of coupling of ␤ 3 -AR splice variants to G ␣ s and G ␣ i used a saturating dose of receptor agonist and assessed the recruitment and activation of the G ␣ q component of each chimera (G ␣ q/s and G ␣ q/i) based on the magnitude and pattern of calcium mobilization. As reported earlier in RESULTS, initial studies established that our transfection protocol with ␤ 3A -AR and ␤ 3B -AR resulted in equivalent receptor expression, as judged by measurements of receptor binding and agonist-dependent coupling to endogenous G ␣ s in both intact cells and cell membranes. A second important control was to show that our transfection protocol with ␤ 3A -AR, ␤ 3B -AR, and the G protein chimeras produced equivalent coupling of each receptor splice variant to the G ␣ q/s chimera. The temporal patterns of CL-316243-dependent mobilization of Ca 2ϩ i in CHO cells transfected with G ␣ q/s and ␤ 3A -AR or ␤ 3B -AR were heterogeneous for each receptor (Fig. 7) . In ϳ30% of cells transfected with each receptor and G ␣ q/s, the agonist produced a single rapid increase in Ca 2ϩ i followed by a monophasic decline to basal calcium over the next 3-4 min (Fig. 7, A and  B) . The peak amplitude and temporal patterns of decay were similar to the response seen with the highest dose of carbachol in M1-CHO cells (Fig. 6A) , and the responses did not differ between ␤ 3A -AR-and ␤ 3B -AR-transfected cells (Fig. 7, A and  B) . The remaining 70% of cells transfected with G ␣ q/s and the ␤ 3 -AR splice variants responded to CL-316243 in an oscillatory manner (Fig. 7, C and D) that was similar to the response observed with low agonist levels in M1-CHO cells (Fig. 6C) . Cells responding to agonist with either the monotonic or oscillatory pattern of calcium mobilization were typically both found on the same plate, and cells displaying the two response types showed no consistent differences in DsRed expression. The estimates of frequency of the two response types were based on analysis of 6 -8 cells per plate and 8 -10 plates per receptor splice variant. It was particularly interesting that no intermediate patterns of calcium mobilization, like those produced with 10 nM carbachol in M1-CHO cells, were observed with either ␤ 3 -AR splice variant. The underlying reasons are unclear, although experiments with lower, nonsaturating concentrations of receptor agonist may have produced the intermediate pattern within the subpopulation of cells responding with monotonic responses. To objectively compare the oscillatory responses between the subpopulations of cells transfected with each receptor splice variant, the temporal patterns of calcium mobilization were analyzed by comparing peak amplitude, peak duration, and interval between peaks. In the subpopulation of cells showing the oscillatory response to agonist, no evidence was found to support the hypothesis that the peak amplitude (P Ͼ 0.05), peak duration (P Ͼ 0.05), or interval between peaks (P Ͼ 0.05) differed between receptor splice variants coupled with G ␣ q/s (Fig. 7, C and D) . And although not shown, the parameter estimates for the rat ␤ 3 -AR were similar to those obtained with the mouse receptors. CHO cells stably transformed with the 5-HT 1A serotonin receptor and transfected with G ␣ q/i were used as a positive control for G ␣ i-preferring receptors. Treatment of cells with 10 M serotonin produced both monotonic and oscillatory patterns of calcium mobilization with peak amplitudes and durations similar to those observed with ␤ 3 -ARs and G ␣ q/s (data not shown).
In contrast, in cells transfected with G ␣ q/i and ␤ 3 -AR splice variants, 100% of the cells examined responded to agonist with an oscillatory pattern of calcium mobilization (Fig. 8) . Collectively, the analysis shows that the two receptor splice variants produced equivalent patterns of calcium mobilization and provides no evidence that the two receptors couple differently from G ␣ i.
Using data from the single-cell imaging approach to provide a quantitative assessment of relative coupling of ␤ 3A -AR and ␤ 3B -AR to G ␣ s vs. G ␣ i is complicated by the heterogeneity of responses with G ␣ q/s (see Fig. 7 ). When peak amplitude is the basis for comparison, analysis of variance provides no evidence of a receptor isoform ϫ G protein interaction (P Ͼ 0.05) or differences in response attributable to receptor isoform (P Ͼ 0.05). However, differences in response between G proteins, averaged across receptor isoform, were significant (P Ͻ 0.01) and accounted for the majority of variance among the groups. The absence of monotonic patterns of calcium mobilization in cells transfected with G ␣ q/i and the lower average peak amplitudes, compared with G ␣ q/s, are consistent with more effective ␤ 3 -AR coupling to G ␣ q/s. The differences were more subtle when the analysis was restricted to a comparison of G ␣ q/s-or G ␣ q/i-transfected cells that responded with an oscillatory pattern of calcium mobilization. For instance, peak amplitude did not differ between G ␣ q/s and G ␣ q/i (Fig. 7, C  and D, vs. Fig. 8, A and B) . However, the intervals between peaks were significantly longer (P Ͻ 0.05) in cells transfected with G ␣ q/i (␤ 3A -AR 151 Ϯ 21 s, ␤ 3B -AR 156 Ϯ 5 s) than with G ␣ q/s (␤ 3A -AR 40 Ϯ 9 s, ␤ 3B -AR 41 Ϯ 10 s), irrespective of the receptor splice variant. This translates into fewer peaks per unit time with G ␣ q/i vs. G ␣ q/s and significantly less calcium mobilization in response to receptor activation. Although this analysis does not provide a quantitative measurement of the relative coupling of the ␤ 3 -AR splice variants to G ␣ q/s vs. G ␣ q/i, the data support a significant albeit less effective coupling of each receptor to G ␣ q/i than to G ␣ q/s. Moreover, this finding is consistent with conclusions reached independently using the high-throughput approach with the rat ␤ 3 -AR and G protein chimeras.
DISCUSSION
Many receptors are known to be promiscuous in the sense that they couple with more than one class of G protein ␣-subunit (11, 16, 33, 42) . In such cases, receptor activation produces a complex array of signals to effector systems that translate the response to agonist in a given cell context. Previous work provided indirect evidence that the ␤ 3 -AR coupled to both G ␣ s and G ␣ i in rat adipocytes (4) . The authors resolved the dual interaction by blocking receptor coupling to G ␣ i with PTX, and showing enhanced signaling through G ␣ s (4). Using a GTP photoaffinity probe, Soeder et al. (40) showed that a ␤ 3 -AR agonist increased binding of AA-GTP to proteins migrating at 40 -42 kDa and presumed to be G ␣ i in membranes from rat white adipocytes. The rationale for the present work stems from work by Evans et al. (13, 23) , showing that alternative splicing of the mouse ␤ 3 -AR gene produced two isoforms (␤ 3A -AR and ␤ 3B -AR) that differ in 
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␤3A-AND ␤3B-ADRENERGIC RECEPTOR COUPLING TO G PROTEINS their COOH-terminal sequence and ability to couple to G ␣ i. They found that the ␤ 3B -AR, but not the ␤ 3A -AR, could activate G ␣ i. Particularly interesting was their finding of tissuespecific expression ratios of the splice variants beween BAT and WAT (13) , where it was reported that mRNA coding for the ␤ 3B -AR represented 21% of total ␤ 3 -AR transcripts in WAT but only 7% in BAT. Although it is unclear whether the encoded proteins are expressed in similar ratios, the predicted paucity of ␤ 3B -AR expression in BAT relative to WAT could produce tissue-specific translations of agonist input if the ␤ 3A -AR coupled only with G ␣ s (23, 39) . For example, ␤ 3 -ARs activate MAPK through G ␣ i in several (3, 40) but not all (34) white adipocyte cell lines, whereas the evidence supports a G ␣ s-cAMP-PKA-dependent pathway not involving G ␣ i in primary cultures of brown adipocytes (31) . Whether these differences are linked to differential expression of the ␤ 3B -AR between brown and white adipocytes has not been resolved. However, understanding the respective signaling pathways engaged by norepinephrine in each cell type represents a key point in understanding how sympathetic input will be translated in BAT and WAT.
Evidence that ␤ 3A -AR and ␤ 3B -AR differentially couple to G ␣ i is based on observed differences in agonist-dependent increases in cAMP after PTX treatment of cells expressing each receptor isoform (23) . For example, PTX enhanced agonist-dependent increases in cAMP in cells expressing the ␤ 3B -AR but not the ␤ 3A -AR, the inference being that the net increase in cAMP was a measure of ␤ 3B -AR-but not ␤ 3A -ARdependent activation of G ␣ i (23) . By use of this approach, the G ␣ i component of receptor input into adenylyl cyclase activity is measured indirectly as the net change in cAMP in the presence and absence of PTX and assumes that receptor input through G ␣ s is unchanged. To provide a direct measurement of ␤ 3 -AR coupling to G ␣ i in the absence of prior assumptions regarding its coupling to G ␣ s, we developed two independent approaches to provide direct assessments of the relative ability of the mouse ␤ 3 -AR isoforms and the rat ␤ 3 -AR to activate G ␣ i in an agonist-dependent manner. The first approach used expression constructs for G protein chimeras in conjunction with the receptor isoforms to 1) assess the relative coupling of ␤ 3 -ARs to G ␣ i vs. G ␣ s and 2) determine whether ␤ 3A -AR and ␤ 3B -AR splice variants differentially couple to G ␣ i. This general approach was developed by Conklin and Bourne (6) as part of an effort to identify specific receptor/G protein contact sites responsible for conferring signaling specificity (32) . Although additional points of contact are involved in the physical interaction between receptor and G protein, the COOH-terminal heptapeptide is the key structural element that determines the specificity of receptor/G protein interaction (27) . By mutating residues within this region of G ␣ q to match the heptapeptide sequences of G ␣ s or G ␣ i, those authors produced chimeric G proteins that effectively transformed the response to receptor activation from regulation of adenylyl cyclase to activation of phospholipase C and mobilization of Ca 2ϩ i (7) (8) (9) 32) . Using both a high-throughput fluorometric imaging platform and a single-cell-based imaging approach, we found that 1) ␤ 3 -ARs are approximately threefold more effective in activating G ␣ s than G ␣ i, and 2) ␤ 3A -and ␤ 3B -AR splice variants are equally effective in activating G ␣ i.
The second independent approach used to assess ␤ 3 -AR coupling to G ␣ i measured ligand-dependent binding of the photoreactive GTP analog, 4-azidoanilido-[␣-
32 P]-GTP (AA-GTP) in plasma membranes from CHO cells stably transformed with the rat ␤ 3 -AR. The rat ␤ 3 -AR is highly homologous (ϳ95%) to the mouse ␤ 3A -AR (see Fig. 1 ) and produced a threefold increase in AA-GTP binding to G ␣ i in a liganddependent manner. A cell line expressing the canonical G ␣ icoupled 5-HT 1A receptor provided a positive control and showed a serotonin-dependent five-to sixfold increase in AA-GTP binding to the 41-kDa proteins that we identified previously as G ␣ i-2 and G ␣ i-3 (16) . Thus our findings with the rat ␤ 3 -AR are consistent using both approaches and support the conclusion that this receptor activates G ␣ i in a ligand-dependent manner.
The COOH terminus of many receptors contains ubiquitous protein interaction modules (PDZ domains) that sequester proteins that modify G protein coupling and receptor recycling (36, 43, 44) . Although a consensus PDZ domain is not evident in the COOH terminus of mouse ␤ 3A -AR, recent work provided evidence that protein-protein interactions with the ␤ 3A -AR COOH terminus were the basis for its inability to interact with G ␣ i (39) in CHO cells. Preincubation with a membrane-permeable peptide corresponding to the COOH terminus of ␤ 3A -AR conferred PTX sensitivity to agonistmediated increases in cellular cAMP (39) , suggesting that interaction of an endogenous protein with the COOH terminus of ␤ 3A -AR prevented its coupling to G ␣ i. If this hypothesis is correct, we predict that preincubation with the peptide should enhance ␤ 3A -AR/G ␣ i interaction and reduce agonist-dependent increases in cAMP.
With both the mouse ␤ 3A -AR and its rat ␤ 3A -AR homolog, we find no evidence of an impaired ability of this receptor isoform to interact with G ␣ i in an agonist-dependent manner. The fundamental difference between the present and previous findings (23, 39) on this point are likely rooted in experimental approach. The PTX approach measures the strength of the ␤ 3 -AR/G ␣ i interaction as a net change (23) in adenylyl cyclase activation and makes the implicit assumption that PTX effects on this response are limited to ADP ribosylation of G ␣ i. Although PTX does prevent receptor-G ␣ i coupling, it has a number of additional effects, including activation of ERK1/2 through a novel pathway (15) , activation of the Toll-like receptor 4 (25) , and activation of tyrosine kinases (28) . Moreover, the catalytically inactive ␤-oligomer of PTX was shown to activate NF-B and alter receptor trafficking to the membrane (24) . It is evident that these effects of PTX have the potential to alter cell function and confound experimental outcomes. In contrast, the two approaches that we took involved direct readouts of G protein activation by the ␤ 3 -AR isoforms. This was accomplished in the first approach with G protein chimeras, which translated receptor-dependent G protein activation into mobilization of Ca 2ϩ i . Therefore, rather than ␤ 3 -AR-mediated activation of G ␣ s and G ␣ i converging on a single effector system (i.e., adenylyl cyclase) and assessment of relative input based on subtraction, the chimeric transformation of the readout provided independent measurements of receptor-dependent input to G ␣ s and G ␣ i. A limitation of this approach is that assembly of protein complexes important to signal integration differs among G proteins, and the G protein chimeras would be expected to form protein complexes similarly to G q ␣ rather than G ␣ i and G ␣ s. This difference has the potential to allow receptor-G protein interactions that might not normally occur. However, our finding that the rat ␤ 3 -AR produced a threefold, agonist-dependent increase in AA-GTP binding to endogenous G ␣ i is consistent with our findings using the chimeras and argues against artifactual receptor-G protein interactions based on the novel structure of the chimeras. It has also become evident that scaffolding and accessory proteins regulate signal processing by recruiting regulatory elements such as activators of G protein signaling family members to receptor-G protein signaling complexes (36, 43, 44) . This represents an additional limitation of the present studies in that the assessment of effector system regulation reflects the unique signaling environment of CHO cells. Therefore, it will be important in future studies to evaluate how the relevant cellular environment of the adipocyte influences the interaction of ␤ 3 -AR splice variants with G protein subtypes.
Notwithstanding these caveats, our results also show that ␤ 3 -ARs couple less efficiently to G ␣ q/i vs. G ␣ q/s. Attempts were made to compare coupling efficiency of the rat ␤ 3 -AR to endogenous G ␣ i vs. G ␣ s using AA-GTP, but significant differences in the Mg 2ϩ concentrations required for optimal binding of AA-GTP to G ␣ i (M) vs. G ␣ s (mM) prevented an objective assessment with this approach (14) . Collectively, our findings indicate that the COOH-terminal sequences produced by alternative splicing of the mouse ␤ 3 -AR gene are not critical determinants for interaction with G ␣ i or G ␣ s and do not contain the structural features that convey the relative preference of ␤ 3 -ARs for G ␣ s over G ␣ i. We estimate that ␤ 3 -ARs coupled to G ␣ i will evoke only one-third the response produced when they couple to G ␣ s. However, this calculation may be influenced by the relative stoichiometry and G protein subtype expression profiles of the cell line being evaluated (18, 38) . For instance, the high levels of G ␣ i subtype (G ␣ i-1, G ␣ i-2, G ␣ i-3) expression in the adipocyte (18) , relative to G ␣ s, could enhance the impact of ␤ 3 -AR-dependent G ␣ i activation and have important effects on translation of catecholaminergic input in adipose tissue.
